Last updated on September 2017

Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)


Brief description of study

A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of anemia and maintenance of Hb in subjects with DD-CKD.

Detailed Study Description

This is a multicenter, randomized, open-label, active-controlled Phase 3 study of the efficacy and safety of vadadustat versus darbepoetin alfa for the correction of anemia and maintenance of Hb in subjects with anemia secondary to CKD who have recently initiated dialysis treatment for end-stage renal disease.

Clinical Study Identifier: NCT02865850

Contact Investigators or Research Sites near you

Start Over

Heather Yaksic

Research Site
Sacramento, CA United States
  Connect »

Heather Yaksic

Research Site
West Sacramento, CA United States
1.94miles
  Connect »